JohnHGlickMD

PubMed

• 6 citations
  The Academy of Master Clinicians: Recognition of Clinical Excellence Within an Academic Medical Center.
  John H. Glick, Victoria Mulhern, Kim M. Olthoff, Jack Ende> ;Academic Medicine. 2017 Aug 1
• 2 citations
  Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Onco...
  Peter H. Wiernik, Fangxin Hong, John H. Glick, John M. Bennett> ;Leukemia & Lymphoma. 2009 Oct 8
• 22 citations
  Doxorubicin Cardiotoxicity in the Elderly: Old Drugs and New Opportunities
  Joseph R. Carver, Stephen J. Schuster, John H. Glick> ;Journal of Clinical Oncology. 2008 Jul 1
• 36 citations
  Should randomized clinical trials be required for proton radiotherapy? An alternative view.
  Eli Glatstein, John H. Glick, Larry R. Kaiser, Stephen M. Hahn> ;Journal of Clinical Oncology. 2008 May 20
• 8 citations
  Primary mucosa-associated lymphoid tissue lymphoma of the breast
  R.R. Rajendran, Juan P. Palazzo, Gordon F. Schwartz, John H. Glick, Lawrence J. Solin> ;Clinical Breast Cancer. 2008 Apr 1
• 80 citations
  First-select the target: better choice of adjuvant treatments for breast cancer patients.
  Aron Goldhirsch, Alan S. Coates, Richard D. Gelber, John H. Glick, Beat Thürlimann, H.-J. Senn> ;Annals of Oncology. 2006 Dec 1
• 21 citations
  Fatal thrombosis after mitral valve replacement for endocarditis: aprotinin and disseminated intravascular coagulation.
  John G.T. Augoustides, Todd J. Kilbaugh, Hilary Harris, John H. Glick, Michael A. Acker, Joseph S. Savino> ;Anesthesiology. 2006 Jan 1
• 910 citations
  Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
  A. Goldhirsch, John H. Glick, Richard D. Gelber, Alan S. Coates, Beat Thürlimann, H.-J. Senn, Panel Members> ;Annals of Oncology. 2005 Oct 1
• 34 citations
  Ethnic disparities in adjuvant chemotherapy for breast cancer are not caused by excess toxicity in black patients
  Karen L. Smith, Lisa Wray, Melissa Klein-Cabral, Lynn M. Schuchter, Kevin Fox, John H. Glick, Angela DeMichele> ;Clinical Breast Cancer. 2005 Aug 1
• 49 citations
  Drug-Metabolizing Enzyme Polymorphisms Predict Clinical Outcome in a Node-Positive Breast Cancer Cohort
  Angela DeMichele, Richard Aplenc, Jeffrey Botbyl, Theresa Colligan, Lisa Wray, Melissa Klein-Cabral, Andrea S. Foulkes, Phyllis A. Gimotty, John H. Glick, Barbara L. W...> ;Journal of Clinical Oncology. 2005 Aug 20
• 249 citations
  Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484
  Sandra J. Horning, Edie Weller, Kyung Mann Kim, John D. Earle, Michael J. O'connell, Thomas M. Habermann, John H. Glick> ;Journal of Clinical Oncology. 2004 Aug 1
• 81 citations
  Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience
  Roberto J Santiago, Leester Wu, Eleanor E.R. Harris, Kevin Fox, Delray Schultz, John H. Glick, Lawrence J. Solin> ;International Journal of Radiation Oncology, Biology, Physics. 2004 Jan 1
• 28 citations
  Phase II randomized trial of cisplatin and WR-2721 versus cisplatin alone for metastatic melanoma: An Eastern Cooperative Oncology Group Study (E1686)
  Donna Glover, Joseph G. Ibrahim, John M. Kirkwood, John H. Glick, Daniel D. Karp, James A. Stewart, Marian Ewell, Ernest C. Borden> ;Melanoma Research. 2003 Dec 1
• 90 citations
  Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible...
  Angela DeMichele, Mary E. Putt, Yawei Zhang M.D., John H. Glick, Sandra A. Norman> ;Cancer. 2003 May 1
• 78 citations
  Ten-year outcome after combined modality therapy for inflammatory breast cancer.
  Eleanor E.R. Harris, Delray Schultz, Helaine Bertsch, Kevin Fox, John H. Glick, Lawrence J. Solin> ;International Journal of Radiation Oncology, Biology, Physics. 1998 Jan 1
• 11 citations
  Natural Killer-like T-Cell Lymphoma of the Small Intestine With a Distinct Immunophenotype and Lack of Association With Gluten-Sensitive Enteropathy
  Constance M. Yuan, Steven Stein, John H. Glick, Mariusz A. Wasik> ;Archives of Pathology & Laboratory Medicine. 2003 Mar 1
• 356 citations
  Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup Trial
  David B. Duggan, Gina R. Petroni, Jeffrey L. Johnson, John H. Glick, Richard I. Fisher, Joseph M. Connors, George P. Canellos, Bruce A. Peterson> ;Journal of Clinical Oncology. 2003 Feb 15
• 11 citations
  Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast ...
  Kevin A. Schulman, Edward A. Stadtmauer, Shelby D. Reed, Henry A. Glick, Lori J. Goldstein, J M Pines, J A Jackman, S Suzuki, Michael Styler, Pamela Crilley, Thomas R....> ;Bone Marrow Transplantation. 2003 Feb 1
• 439 citations
  Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Can...
  A. Goldhirsch, John H. Glick, Richard D. Gelber, A. S. Coates, H.-J. Senn> ;Journal of Clinical Oncology. 2001 Sep 15
• 225 citations
  The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience.
  John H. Chang, Eugenio Vines, Helaine Bertsch, Douglas L. Fraker, Brian J. Czerniecki, Ernest F. Rosato, Thomas Lawton, Emily F. Conant, Susan G. Orel, Lynn M. Schucht...> ;Cancer. 2001 Apr 1
• Bleomycin, Lomustine, Cyclophosphamide, Vincristine, Procarbazine and Prednisone (BLEO-CCVPP) in Patients with Hodgkin's Disease who Relapsed after Radiotherapy Alone:...
  Peter H. Wiernik, Traci Leong, Martin M. Oken, Richard S. Neiman, Thomas M. Habermann, John M. Bennett, Stephen J. Schuster, John H. Glick> ;Leukemia & Lymphoma. 2001 Jan 1
• 20 citations
  Analysis of outcomes for high-risk breast cancer based on interval from surgery to postmastectomy radiation therapy.
  Metz Jm, Delray Schultz, Kevin Fox, Mathews A, John H. Glick, Lawrence J. Solin> ;Cancer Journal. 2000 Sep 1
• 1 citations
  Stage III and IV Hodgkin's disease treatment guidelines. American College of Radiology. ACR Appropriateness Criteria.
  Leonard R. Prosnitz, Jean M. Connors, Deming Rl, Joachim Yahalom, Mauch Pm, Louis S. Constine, Dosoretz De, Elman Aj, Hoppe Rt, Pistenmaa Da, Wolkov Hb, Chauvenet A, J...> ;Radiology. 2000 Jun 1
• 1 citations
  Follow-up of Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria.
  Deming Rl, Louis S. Constine, Elman Aj, Richard T. Hoppe, Peter Mauch, Dosoretz De, Pistenmaa Da, Leonard R. Prosnitz, Wolkov Hb, Joachim Yahalom, Allen R. Chauvenet, ...> ;Radiology. 2000 Jun 1
• 1 citations
  Staging evaluation for patients with Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria.
  Wolkov Hb, Elman Aj, Richard T. Hoppe, Pistenmaa Da, Peter Mauch, Louis S. Constine, Deming Rl, Dosoretz De, Leonard R. Prosnitz, Joachim Yahalom, Allen R. Chauvenet, ...> ;Radiology. 2000 Jun 1
• Join now to see all

Journal Articles

• Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma; a study by the Eastern Co-operative Onco...  
  Wiernik PH, Hong F, Glick JH, Bennett JM, Leukemia Lymphoma, 1/1/2009
• Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer  
  Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thurlimann B, Senn JH and Panel Members, Annals of Oncology, 1/1/2009
• Primary Mucosa-associated Tissue Lymphoma of the Breast  
  Rajendran RR, Palazzo, JP, Schwartz GF, Glick JH, Solin L, Clinical Breast Cancer, 1/1/2008
• Should Randomized Clinical Trials Be Required for Proton Radiotherapy? An Alternative View  
  Glatstein E, Glick JH, Kaiser L, Hahn S, J Clin Oncol, 1/1/2008
• First-Select the Target: Better Choice of Adjuvant Treatments for Breast Cancer Patients  
  Goldhirsch A, Coates A, Gelber R, Glick J, Thurlimann B, Senn HJ, Annals of Oncology, 1/1/2006
• Ethnic Disparities in Adjuvant Chemotherapy for Breast Cancer are Not Caused by Excess Toxicity in Black Patients  
  Smith K, Wray L, Klein-Cabral M, Schuchter L, Fox K, Glick JH, DeMichele A, Clinical Breast Cancer, 1/1/2005
• International Expert Consensus on the Primary Therapy of Early Breast Cancer, 2005  
  Goldhirsch A, Glick J, Gelber R, Coates A, Thurlimann B, Senn HJ, Annals of Oncology, 1/1/2005
• Fifteen-Year Results of Breast-Conserving Surgery and Definitive Irradiation for Stage I and II Breast Carcinoma: The University of Pennsylvania Experience  
  Santiago RJ, Wu L, Harris E, Fox K, Schultz D, Glick JH, Solin LJ, Int J Radiation Oncology Biol Physics, 1/1/2004
• Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484  
  Horning SJ, Weller E, Kim KM, Earle JD, O'Connell MJ, Habermann TM, Glick JH, J Clin Oncol, 1/1/2004
• Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast ...  
  Schulman KA, Stadtmauer EA, Reed SD, Glick HA, Goldstein LJ, Pines J, Jackman JA, Suzuki S, Styles MJ, Crilley PA, Klumpp TR, Mangan K, Glick JH, Bone Marrow Transplantation, 1/1/2003
• Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin's Disease: Report of an Intergroup Trial  
  Duggan DB, Petroni GR, Johnson JL, Glick JH, Fisher RI, Connors JM, Canellos GP, Petersono BA, J Clin Oncol, 1/1/2003
• Phase II randomized trial of cisplatin and WR-2721 versus cisplatin alone for metastatic melanoma: an Eastern Cooperative Oncology Group Study (E1686)  
  Glover D, Ibrahim J, Kirkwood J, Glick J, Karp D, Stewart J, Ewell M, Borden E; Eastern Cooperative Oncology Group, Melanoma Res, 1/1/2003
• The Impact of a Multidisciplinary Breast Cancer Center on Recommendations for Patient Management: The University of Pennsylvania Experience  
  Chang JH, Vines E, Bertsch H, Fraker DL, Czerniecki BJ, Rosato EF, Lawton T, Conant EF, Orel SG, Schuchter L, Fox KR, Zieber N, Glick JH, Solin LJ, Cancer, 1/1/2001
• Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer  
  Goldhirsch A, Glick JH, Gelber RD., Coates AS, Senn HJ, J Clin Oncol, 1/1/2001
• Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone;...  
  Wiernik PH, Leong T, Oken MM, Neiman RS, Habermann TM, Bennett JM, Schuster S, Glick JH, Leuk Lymphoma, 1/1/2001
• Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy Plus Autologous Hematopoietic Stem Cell Tansplantation in Metastatic Breast Cancer  
  Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley PA, Mangan KF, Ingle JN, Luger SM, Klumpp TR, Brodsky I, Litzow MR, Martino S, Lazarus HM, Erban JK, Sickles C, Glick JH, New Engl J Med, 1/1/2000
• Analysis of Outcomes for High-Risk Breast Cancer Based on Interval from Surgery to Postmastectomy Radiation Therapy  
  Metz JM, Schultz DJ, Fox K, Mathews A, Glick J, Solin LJ, The Cancer Journal, 1/1/2000
• Follow-up of Hodgkin's disease  
  Deming RL, Constine LS, Elman AJ, Hoppe RT, Mauch PM, Dosoretz DE, Pistenmaa DA, Prosnitz LR, Wolkov HB, Yahalom J, Chauvenet A, Connors JM, Glick JH, Leibel S, American College of Radiology. ACR Appropriateness Criteria. Radiology, 1/1/2000
• Stage III and IV Hodgkin's disease treatment guidelines  
  Prosnitz LR, Connors JM, Deming RL, Yahalom J, Mauch PM, Constine LS, Dosoretz DE, Elman AJ, Hoppe RT, Pistenmaa DA, Wolkov HB, Chauvenet A, Glick JH, Leibel S, American College of Radiology. ACR Appropriateness Criteria. Radiology, 1/1/2000
• Pediatric Hodgkin's disease  
  Constine LS, Wolkov HB, Yahalom J, Mauch PM, Deming RL, Dosoretz DE, Elman AJ, Hoppe RT, Pistenmaaa DA, Prosnitz LR, Chauvenet A, Connors JM, Glick JH, Leibel S, American College of Radiology. ACR Appropriateness Critera, 1/1/2000
• Pediatric Hodgkin's disease  
  Constine LS, Wolkov HB, Yahalom J, Mauch PM, Deming RL, Dosoretz DE, Elman AJ, Hoppe RT, Pistenmaaa DA, Prosnitz LR, Chauvenet A, Connors JM, Glick JH, Leibel S, American College of Radiology. ACR Appropriateness Criteria. Radiology, 1/1/2000
• Staging evaluation for patients with Hodgkin's disease  
  Wolkov HB, Elman AJ, Hoppe RT, Pistenmaa DA, Mauch PM, Constine LS, Deming RL, Dosoretz DE, Prosnitz LR, Yahalom J, Chauvenet A, Connors JM, Glick JH, Leibel S, American College of Radiology. ACR Appropriateness Criteria. Radiology, 1/1/2000
• Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local regional recurrence  
  Metz JM, Schultz DJ, Fox K, Glick J, Solin LJ, The Cancer Journal, 1/1/1999
• A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: An Eastern Cooperative Oncology G...  
  Tester WJ, Kim KM, Krigel RL, Bonomi PD, Glick JH, Asbury RF, Kirkwood JM, Blum RH, Schiller JH, Lung Cancer, 1/1/1999
• A Phase II Trial of 200% ProMACE-CytaBOM in Patients with Previously Untreated Aggressive lymphomas: Analysis of response, toxicity and dose intensity  
  Gordon LI, Young M, Weller E, Habermann TM, Winter JN, Glick JH, Ghosh C, Flynn P, Cassileth PA, Blood, 1/1/1999
• Join now to see all

Books/Book Chapters

• Diseases of the Breast 
  Chapter: Local-Regional Recurrence After Breast Conservation Treatment or Mastectomy 
  Page 1067 - 1087Solin LJ, Harris EER, Orel SG, Glick JHEditors: Harris JR, Lippman ME, Morrow M, Hellman S.2004
• Principles and Practice of Geriatric Medicine 
  Chapter: Cancer in the Elderly 
  Page 1457 - 1467Vaughn DJ, Glick JHEditors: M.S.M. Pathy.2000
• Hematology: Basic Principles and Practice 
  Chapter: Hodgkin's Disease: Clinical Manifestations, Staging and Therapy 
  Page 1241 - 1262Portlock CS and Glick JHEditors: Hoffman, et al.Churchill Livingstone, New York, NY2000
• The American Cancer Society's Clinical Oncology 
  Chapter: Cancer-Related Emergencies 
  Page 733 - 764DeMichele A and Glick JHEditors: Lenhard RE, Osteen RT and Gansler R.American Cancer Society, Atlanta, GA2000
• Textbook of Internal Medicine 
  Chapter: Oncology-Hematology 
  Editors: Glick JH (Associate Editor), W Kelley.Lippincott-Raven, Philadelphia, PA1997
• Cancer: Principles & Practice of Oncology 
  Chapter: Radiation and Chemotherapy Protectors 
  Schuchter LM, Meropol N, Glick JHEditors: DeVita VT, Hellman S and Rosenberg SA.J. H. Lippincott Company, Philadelphia, PA1997
• American Cancer Society Textbook of Clinical Oncology 
  Chapter: Oncologic Emergencies 
  Page 597 - 618Glick JH and Glover DEditors: Murphy EP, Lawrence W Jr., Lenhard RE Jr..ACSEdition 2nd,1995
• Medical Oncology 
  Editors: Glick JH (Associate Editor), P. Calabresi and P. Schein.McGraw Hill, New York, NYEdition 2nd,1993
• Medical Oncology 
  Chapter: Oncologic Emergencies and Special Complications 
  Page 1021 - 1072Glover DJ , Grabelsky S, and Glick JHEditors: P Calabresi, P Schein.McGraw Hill, New York, NYEdition 2nd,1993
• Hematology: Basic Principles and Practice 
  Chapter: Hodgkin's Disease: Clinical Manifestations, Staging and Therapy 
  Page 1226 - 1246Glick JH and Portlock CSEditors: Benz EJ, Cohen HJ, Furie B, R. Hoffman, Shattil S.Churchill Livingstone, New York, NYEdition 2nd,1993
• Medical Oncology 
  Editors: Glick JH (Associate Editor), P. Calabresi and P. Schein.McGraw Hill, New York, NYEdition 2nd,1993
• Breast Cancer Treatment: A Comprehensive Guide for Management 
  Chapter: Adjuvant Therapy for Node Negative Breast Cancer 
  Page 243 - 264Glick JHEditors: B. Fowble.Mosby1991
• Clinical Oncology 
  Chapter: Oncologic Emergencies 
  Page 513 - 533Glick JH and Glover DJEditors: Fink D , Murphy G, Holland, A..American Cancer Society1991
• Breast Cancer Treatment: A Comprehensive Guide for Management 
  Editors: Glick JH (Associate Editor), B. Fowble.1991
• Breast Cancer Treatment: A Comprehensive Guide for Management 
  Editors: Glick JH (Associate Editor), B. Fowble.1991
• Hematology: Basic Principles and Practice 
  Chapter: Hodgkin's Disease: Clinical Manifestations, Staging, and Treatment 
  Page 921 - 938Glick JH, Portlock CEditors: Benz EJ, Cohen HJ, Furie B, R. Hoffman, Shattil S..Churchill Livingstone, New York, NY1990
• Clinical Decisions in Oncology 
  Chapter: Breast Cancer 
  Page 100 - 115Glick JHEditors: P. Schein.B.C. Decker, Inc.1989
• New Chemo and Radiosensitizing Drugs 
  Chapter: Radiation damage and radioprotective processes: Including a status report on clinical applications of WR-2721 
  Page 153 - 162Kligerman MM, Turrisi AT, Glover DJ, Norfleet AL, Glick JHEditors: A Breccia and JF Fowler.1985
• Medical Oncology 
  Chapter: Medical Oncology 
  Page 1261 - 1326Glover DJ and Glick JHEditors: P Calabresi, P Schein, and S. Rosenberg.Macmillan, New York, NY1985
• Cecil's Textbook of Medicine 
  Chapter: Hodgkin's Disease 
  Page 1000 - 1009Glick JHEditors: JB Wyngaarden and LH Smith, Jr..W.B. SaundersEdition 17th,1985
• Adjuvant Therapy of Cancer IV 
  Chapter: Integration of adjuvant chemotherapy with definitive radiotherapy for primary breast cancer 
  Page 291 - 300Glick JH, Danoff B, Haller D, Weiler C, Hurwitz S, Richter M, Goodman REditors: Jones SE, Salmon SE.New York, NY, Grune & Stratton1984
• Breast Cancer: Alternatives to Mastectomy 
  Chapter: Adjuvant chemotherapy in patients undergoing definitive irradiation for primary breast cancer: The University of Pennsylvania experience 
  Page 311 - 320Glick JH, Danoff BF, Haller DG, Weiler C, Goodman REditors: Harris J, Hellman S, Silen W.Philadelphia, PA, Lippincott1983
• Radioprotectors and Anticarcinogens 
  Chapter: Clinical trials of WR-2721 and chemotherapy 
  Page 719 - 734Glick JH, Glover D, Turrisi A, Weiler C, Yuhas J, Kligerman MEditors: Nygaard OF, Simic M.New York, NY, Academic Press1983
• Controversies in the Management of Lymphomas 
  Chapter: Nodular Mixed Lymphoma: Failure to Demonstrate Prolonged Disease-Free Survival Cure 
  Page 239 - 256Glick JH and Orlow EREditors: JM Bennett.Martinus Nijhoff Publishers, The Hague1983
• Practical Approaches to Hematology-Oncology 
  Cassileth PA, Cooper RA, Glick JH, Negendank WMedical Examination Publishing Co., Inc., New York, NY1982
• Join now to see all

Abstracts/Posters

• Fifteen-Year Results of Breast-Conserving Surgery and Definitive Irradiation for Stage I and II Breast Carcinoma: The University of Pennsylvania Experience
  Santiago RJ, Wu L, Harris E, Fox K, Schultz D, Glick JH, Solin LJ, American Society of Clinical Oncology, 38th Annual Meeting, Orlando, FL, 5/1/2002
• A Phase I/II dose escalating trial of liposomal doxorubicin (TLCD-99, Myocet) in combination with paclitaxel (Taxol, T) for patients with metastatic breast cancer
  Welles L, Miller WH Jr, Fox K, Batist G, Glick JH, DeMichele A, American Society of Clinical Oncology, Orlando, FL, 1/1/2002
• Racial differences in hematologic tolerability of adjuvant chemotherapy in breast cancer patients
  DeMichele A, Smith K, Wray L, Klein-Cabral M, Fox K, Schuchter L, Glick JH, American Society of Clinical Oncology, Orlando, FL, 1/1/2002
• Final Report of E1484: CHOP v. CHOP + Radiotherapy (RT) for Limited Stage Diffuse Aggressive Lymphoma
  Horning SJ, Glick JH, Kim K, Earle J, O'Connell MJ, Habermann T, Weller E, Gray R, American Society of Hematology, 1/1/2001
• Phase II trial of high dose chemotherapy and peripheral blood stem cell support for women with locally advanced, inoperable, or inflammatory breast cancer with chemose...
  Goldstein LJ, Crilley P, Stadtmauer E, Mangan K, Luger S, Topolsky D, Dexter D, Klumpp T, Sickles C, Biggs D, Solin L, Glick JH, American Society of Clinical Oncology, New Orleans, LA, 1/1/2000
• Economic analysis of high dose chemotherapy and stem cell support vs. standard dose chemotherapy for women with responding metastatic breast cancer in the Philadelphia...
  Shulman KA, Glick HA, Goldstein LJ, Pines J, Jackman J, Suzuki S, Styles M, Crilley P, Mangan K, Glick JH, American Society o Clinical Oncology, Annual Meeting, New Orleans, LA, 1/1/2000
• Quality of life experience in women randomized to high-dose chemotherapy and stem cell support or standard dose chemotherapy for responding metaststic breast cancer in...
  Daly MB, Goldstein LJ, Topolsky D, Klumpp T, Russ E, Gillespie D, Allen S, Mangan K, Sickles C, Glick JH, Stadtmauer E, American Society of Clinical Oncology, Annual Meeting, New Orleans, LA, 1/1/2000
• Phase II trial of high dose chemotherapy and peripheral blood stem cell support for women with locally advanced, inoperable, or inflammatory breast cancer with chemose...
  Goldstein LJ, Crilley P, Stadtmauer E, Mangan K, Luger S, Topolsky D, Dexter D, Klumpp T, Sickles C, Biggs D, Solin L, Glick JH, American Society of Clinical Oncology, New Orleans, LA, 1/1/2000
• Phase III randomized trial of high-dose chemotherapy (HDC) and stem cell support (SCT) sows no difference in overall survival or severe toxicity compared to maintenanc...
  Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley P, Mangan KF, Ingle JN, Lazarus HM, Erban J, Sickles C, Glick JH, ASCO, Annual Meeting, Atlanta, GA, 1/1/1999
• Phase III randomized trial of high-dose chemotherapy (HDC) and stem cell support (SCT) sows no difference in overall survival or severe toxicity compared to maintenanc...
  Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley P, Mangan KF, Ingle JN, Lazarus HM, Erban J, Sickles C, Glick JH, ASCO, Annual Meeting, Atlanta, GA, 1/1/1999
• Ten year outcome after combined modality therapy for inflammatory breast cancer
  Bertsch HF, Fox K, Schultz DJ, Staley J, Glick JH, Solin LJ, ASTRO, Annual Meeting, 1/1/1998
• Palliative mitoguazone (MGBG) therapy for advanced Hodgkin's disease following intensive therapy and autologous bone marrow reconstruction
  Fay J, Giles F, Glick J, Goldberg J, Howard O, Kurzrock R, Morganstern D, Nixon D, Remick S, Rosen F, Younger J, Smith S, Santabarbara P, Williams T, American Society of Clinical Oncology, Annual Meeting, Los Angeles, CA, 1/1/1998
• Long term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local - regional recurrence
  Metz JM, Schultz D, Fox K, Glick J, and Solin LJ, American Society of Clinical Oncology, Annual Meeting, Los Angeles, CA, 1/1/1998
• Phase II trial of dose escalation in diffuse aggressive lymphomas (DAL): Response and toxicity with 200% ProMACE-CytaBOM
  Gordon LI, young M, Habermann T, Glick JH, Winter J, Schilder R, Cassileth P, American Society of Clinical Oncology, Denver, CO, 1/1/1997
• MOPP/ABV versus ABVD for advanced Hodgkin's disease: A preliminary report
  Duggan D, Petroni G, Johnson J, Hanson K, Glick J, Conners JM, Cherny R, Bareos M, Peterson BA, American Society of Clinical Oncology, Denver, CO, 1/1/1997
• Expression of Apoptosis-Regulatory Proteins Bcl-2, Bax, and Caspase-3 in Non-Hodgkin's Lymphomas: An ECOG Study (E6491)
  Krajewska M, Krajewski S, Young M, Weller E, Neiman R, Mederios J, Glick J, Venkatrai U, Gordon L, Cassileth P, Reed JC, American Society of Hematology, Annual Meeting, 1/1/1997
• A phase II trial of biweekly paclitaxel and cisplatin in patients with advanced breast carcinoma: An Eastern Cooperative Oncooogy Group (ECOG) trial (E1194)
  Sparano JA, Neuberg D, Wood W, Glick JH, Robert NJ, Sledge GW, Goldstein LJ, American Society of Clinical Oncology, Philadelphia, PA, 1/1/1996
• Ethyol (Amifostine) Protects Against Cumulative Cisplatin Toxicities
  Rose P, Kemp G, Glick JH, American Society of Clinical Oncology, Philadelphia, PA, 1/1/1996
• A phase II trial of biweekly paclitaxel and cisplatin in patients with advanced breast carcinoma
  parano JA, Neuberg D, Glick JH, Robert N, Goldstein LJ, Sledge GW, Wood W, American Society of Clinical Oncology, Philadelphia, PA, 1/1/1996
• Concurrent chemotherapy and radiation for breast conservation therapy of early stage breast cancer
  Markiewicz D, Fox K, Schultz D, Harris E, Haas J, Glick JH, Solin L, American Society of Clinical Oncology, Philadelphia, PA, 1/1/1996
• The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conserving surgery and radiation therapy in stage I a...
  Markiewicz DA, Schultz DJ, Haas JA, Harris EER, Fox KR, Glick JH, Solin LJ, ASTRO, Miami, FL, 1/1/1995
• Suppression of estrogens and possible increasead cleavance of estrone sulfate by rogletimide when used in the treatment of breast cancer
  Fox K, Glick J, Schultz J, Demers L, Conner G, Reynolds R, Mitchell E, Capizzi R, Schein P, American Society of Clinical Oncology, Los Angeles, CA, 1/1/1995
• A Phase II study of rogletimide in females with advanced metastatic breast cancer
  Shultz J, Fox K, Glick J, Capizzi RL, American Society of Clinical Oncology, Los Angeles, CA, 1/1/1995
• An ECOG randomized phase III trial of CHOP vs. CHOP plus radiotherapy for intermediate grade early stage non-Hodgkin's lymphoma
  Glick J, Kim K, Earle J, O'Connell MJ, American Society of Clinical Oncology, Los Angeles, CA, 1/1/1995
• Cost Containment and Eradication of Cancer in the United States
  Glick JH, The Challenges in Studying the Socioeconomic Dimensions in Cancer Therapy, (Proceedings), 1/1/1994
• Join now to see all

Lectures

• Adjuvant Therapy for Early Breast Cancer 
  Multiple Locations, 2001, 2004, 2007, 2011 - 1/1/2011
• Breast Cancer: Recent Advances 
  New Brunswick, NJ - 1/1/2002
• Systemic Therapy for Breast Cancer 
  1/1/2002
• Systemic Therapy for Early Stage Breast Cancer 
  1/1/2000
• Bone Marrow and Stem Cell Transplantation for Breast Cancer 
  1/1/2000
• High Dose Chemotherapy and Bone Marrow and Stem Cell Transplantation for Breast Cancer 
  Miami, FL - 1/1/2000
• How to Manage Difficult Clinical Problems 
  New Orleans, LA - 1/1/2000
• Interface Between Primary Care and Oncology (The Team Approach) 
  Jacksonville, FL - 1/1/1998
• Adjuvant Therapies for Early Stage Breast Cancer 
  New Jersey - 1/1/1997
• Combined Modality Therapy for Hodgkin's Disease and non-Hodgkin's Lymphoma 
  Palm Springs, CA (1997); Temple, TX (1997) - 1/1/1997
• Advances in the Treatment of Lymphomas 
  New York, NY - 1/1/1997
• Role of Cytoprotectants in Chemotherapy 
  Temple, TX - 1/1/1997
• Adjuvant Therapy for Breast Cancer 
  Multiple Locations, 1991, 1992, 1994, 1996 - 1/1/1996
• Adjuvant Therapy for Early Stage Breast Cancer 
  Multiple Locations, 1994, 1995, 1996, 1999 - 1/1/1996
• American Society of Clinical Oncology 
  Bethesda, MD - 1/1/1996
• Presidential Address 
  Philadelphia, PA - 1/1/1996
• Recent Advances in the Treatment of Advanced Hodgkin's Disease 
  Chicago, IL - 1/1/1995
• Adjuvant Therapy for Node Negative Breast Cancer 
  Multiple Locations, 1991, 1992, 1994 - 1/1/1994
• Advanced Hodgkin's Disease 
  South Africa - 1/1/1994
• Node Negative Breast Cancer 
  Buffalo, NY - 1/1/1993
• Advances in Staging and Treatment of Intermediate Grade Non-Hodgkin's Lymphoma 
  Pennsylvania, PA - 1/1/1993
• Non-Hodgkin's Lymphoma 
  Baltimore, MD - 1/1/1993
• Adjuvant Therapy for Primary Breast Cancer 
  Omaha, NE (1991); St. Gallen, Switzerland (1992) - 1/1/1992
• Recent Advances in the Treatment of Hodgkin's Disease 
  Rochester, NY (1992) - 1/1/1992
• Adjuvant Therapy for Node-Negative Breast Cancer 
  Minneapolis, MN - 1/1/1992
• Join now to see all